Safety and efficacy of MT10107 in post-stroke upper limb spasticity treatment: A phase I randomized controlled trial.
June-Kyung LeeMin Ho ChunYoung Jin KoShi-Uk LeeDeog Young KimNam-Jong PaikPublished in: Medicine (2022)
The safety and efficacy of MT10107 showed no significant difference compared to onabotulinumtoxinA in post-stroke upper limb spasticity treatment.